Reactome Pathway Database

Schema > Person > Entries

Chiarle, R Show undefined attributes

created [InstanceEdit:9667875] Orlic-Milacic, Marija, 2019年11月18日

dbId 9667884

displayName Chiarle, R

firstname Roberto

initial R

publications

[LiteratureReference:9667881] The anaplastic lymphoma kinase in the pathogenesis of cancer
[LiteratureReference:9701357] Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
[LiteratureReference:9701343] NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors
[LiteratureReference:9701321] Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
[LiteratureReference:9850777] NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells
[LiteratureReference:9850784] The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathway
[LiteratureReference:9725240] Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes
[LiteratureReference:9710822] The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration
[LiteratureReference:9701354] ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis
[LiteratureReference:9843025] IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma

schemaClass Person

surname Chiarle

© 2025 Reactome

Cite Us!